Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Soterix Medical, Inc. is a pioneering company in the field of non-invasive neuromodulation and brain stimulation. They specialize in the development, manufacturing, and commercialization of advanced medical devices, including transcranial Direct Current Stimulation (tDCS), transcranial Alternating Current Stimulation (tACS), and High-Definition tDCS (HD-tDCS) systems. Their technologies are utilized by researchers and clinicians worldwide to investigate brain function and explore treatments for a wide range of neurological and psychiatric conditions such as depression, chronic pain, stroke rehabilitation, and epilepsy. Soterix Medical is committed to advancing the science and application of neuromodulation through innovation, rigorous clinical validation, and comprehensive customer support, aiming to improve patient outcomes and expand therapeutic possibilities.
The New York headquarters serves as the company's primary center for research and development, product innovation, engineering, manufacturing oversight, global marketing, sales operations, and corporate administration.
Located in a historic building in Manhattan's Flatiron District, the headquarters provides access to a vibrant tech and research community. The office space itself is modern and designed to support collaborative research and development.
The work culture at Soterix Medical's HQ is characterized by a strong emphasis on scientific innovation, collaboration, and a mission-driven approach to developing neuromodulation therapies. Employees, including engineers, scientists, and medical professionals, work in a dynamic environment that values rigorous research, precision engineering, and tangible contributions to healthcare advancements.
Its New York City headquarters is significant as it places Soterix Medical at the nexus of cutting-edge medical research, technological innovation, and global commerce. This strategic location facilitates collaborations with leading academic institutions and hospitals, access to a highly skilled talent pool, and efficient engagement with the global medical device market.
Soterix Medical maintains a significant global presence, with its neuromodulation devices used by researchers and clinicians in numerous countries across North America, Europe, Asia, and Australia. This worldwide reach is supported through direct sales channels and a network of international distributors who provide local support and facilitate the adoption of Soterix Medical's technologies for clinical trials, research studies, and therapeutic applications globally.
130 Fifth Avenue, Floor 9
New York
NY
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Soterix Medical' leadership includes:
Soterix Medical has been backed by several prominent investors over the years, including:
No specific executive new hires, departures, or transitions have been publicly announced by Soterix Medical in the last 12 months, suggesting stability within the core leadership team.
Discover the tools Soterix Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Soterix Medical likely utilizes standard professional email address formats. The most common format observed or predicted for Soterix Medical is the first initial followed by the last name.
[first_initial][last]@soterixmedical.com
Format
adatta@soterixmedical.com
Example
85%
Success rate
PR Newswire • October 18, 2023
Soterix Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its novel therapeutic device designed to treat motor deficits in stroke survivors. This designation aims to expedite the development and review of medical devices that provide for more effective treatment of debilitating conditions....more
Soterix Medical News • April 12, 2023
Soterix Medical announced the launch of its next-generation transcranial Electrical Stimulation (tES) Lab System. The new system incorporates enhanced features for precision, usability, and flexibility, empowering researchers to conduct more sophisticated studies in non-invasive brain stimulation....more
Soterix Medical News / NIH • September 26, 2022
Soterix Medical was awarded a significant grant from the NIH's HEAL (Helping to End Addiction Long-term) Initiative to develop and test a home-based transcranial Direct Current Stimulation (tDCS) therapy for chronic pain management, aiming to provide a non-opioid alternative for pain relief....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Soterix Medical, are just a search away.